We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current JNJ market cap is 327.58B. The company's latest EPS is USD 5.8423 and P/E is 26.46.
| Year End 29 December 2024 | 2021 | 2022 | 2023 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.58B | 93.78B | 94.94B | 85.16B | 88.82B |
| Operating Income | 19.49B | 23.4B | 23.38B | 21.21B | 20.8B |
| Net Income | 14.71B | 20.88B | 17.94B | 35.15B | 14.07B |
| Year End 29 December 2024 | 2021 | 2022 | 2023 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 174.89B | 182.02B | 187.38B | 167.56B | 180.1B |
| Total Liabilities | 111.62B | 108B | 110.57B | 98.78B | 108.61B |
| Total Equity | 63.28B | 74.02B | 76.8B | 68.77B | 71.49B |
| Year End 29 December 2024 | 2021 | 2022 | 2023 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 23.54B | 23.41B | 21.19B | 22.79B | 24.27B |
| Investing | -20.83B | -8.68B | -12.37B | 878M | -18.6B |
| Financing | -6.12B | -14.05B | -8.87B | -15.83B | -3.13B |
| Market Cap | 327.58B |
| Price to Earnings Ratio | 26.46 |
| Price to Sales Ratio | 4.19 |
| Price to Cash Ratio | 15.44 |
| Price to Book Ratio | 5.21 |
| Dividend Yield | 4.36% |
| Shares Outstanding | 2.41B |
| Average Volume (1 week) | 17.74k |
| Average Volume (1 Month) | 23.12k |
| 52 Week Change | -1.69% |
| 52 Week High | 161.48 |
| 52 Week Low | 128.02 |
| Spread (Intraday) | 0.4 (0.29%) |
| Company Name | Johnson And Johnson |
| Address |
one johnson & johnson plaza new brunswick, new jersey 08933 |
| Website | https://www.jnj.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
